The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 27, 2015

Filed:

Mar. 10, 2014
Applicant:

Max-planck-gesellschaft Zur Forderung Der Wissenschaften E.v., München, DE;

Inventors:

Axel Ullrich, Munich, DE;

Robert Torka, Kaufering, DE;

Yixiang Zhang, Boston, MA (US);

György Kéri, Budapest, HU;

László Örfi, Budapest, HU;

István Szabadkai, Budapest, HU;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 417/12 (2006.01); C07D 215/20 (2006.01); C07D 413/12 (2006.01); C07D 401/14 (2006.01); C07D 409/14 (2006.01); C07D 405/12 (2006.01); C07D 401/12 (2006.01); C07D 409/12 (2006.01);
U.S. Cl.
CPC ...
C07D 417/12 (2013.01); C07D 215/20 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 405/12 (2013.01); C07D 409/12 (2013.01); C07D 409/14 (2013.01); C07D 413/12 (2013.01);
Abstract

The present invention relates to quinolinyloxyphenylsulfonamides and stereoisomeric forms, solvates, hydrates and/or pharmaceutically acceptable salts of these quinolinyloxyphenylsulfonamide compounds as well as pharmaceutical compositions containing at least one of these compounds together with at least one pharmaceutically acceptable carrier, excipient and/or diluent. Said quinolinyloxyphenylsulfonamides are useful for prophylaxsis, treatment and/or after-treatment of hyperproliferative disorders, such as cancer, tumors and particularly cancer metastases.


Find Patent Forward Citations

Loading…